Fast Market Research

Pharma Two B Ltd - Product Pipeline Review - 2013 - New Market Study Published

Fast Market Research recommends "Pharma Two B Ltd - Product Pipeline Review - 2013" from Global Markets Direct, now available


Boston, MA -- (ReleaseWire) -- 02/05/2014 -- Global Market Direct's pharmaceuticals report, "Pharma Two B Ltd - Product Pipeline Review - 2013" provides data on the Pharma Two B Ltd's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Pharma Two B Ltd's corporate website, SEC filings, investor presentations and featured press releases, both from Pharma Two B Ltd and industry-specific third party sources, put together by Global Markets Direct's team.


- Pharma Two B Ltd - Brief Pharma Two B Ltd overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Pharma Two B Ltd human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Pharma Two B Ltd with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Pharma Two B Ltd's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Pharma Two B Ltd's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Pharma Two B Ltd in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Pharma Two B Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Pharma Two B Ltd.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Pharma Two B Ltd and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Lanthio Pharma B.V. - Product Pipeline Review - 2013
- Kiadis Pharma B.V. - Product Pipeline Review - 2013
- B-Cell Lymphomas - Pipeline Review, H2 2013
- Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013
- Zosano Pharma, Inc. - Product Pipeline Review - 2013
- Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2013
- Pfizer Inc. - Product Pipeline Review - 2013
- Novartis AG - Product Pipeline Review - 2013
- H. Lundbeck A/S - Product Pipeline Review - 2013
- Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2013